Header Logo

Kai Yeung, PharmD, PhD

TitleAssistant Investigator
InstitutionKaiser Permanente Washington
DepartmentWashington Health Research Institute
Address1730 Minor Ave
Seattle WA 98101
ORCID ORCID Icon0000-0002-1102-2040 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Kai Yeung, PharmD, PhD, is a pharmacist and scientist with expertise in pharmaceutical economics and outcomes research. He is interested in optimal incentives to encourage value in health care. Dr. Yeung does research in applied econometrics, health insurance design, and cost-effectiveness analysis. He received his PharmD from the University of Southern California and his PhD in pharmaceutical economics from the Pharmaceutical Outcomes Research & Policy Program at the University of Washington.

    Before joining KPWHRI in the fall of 2016, Dr. Yeung was a post-doctoral fellow at the University of Washington where he sought to understand payer acceptability of alternative payment models for high-priced curative therapies. He found that while payers were struggling with the affordability of high-priced cures, they were not aware of new payment models, but when educated by the research team, had high levels of acceptability to some of the new models.

    Dr. Yeung’s dissertation assessed the impact of a novel prescription drug benefit, the Value-Based Formulary (VBF) which used cost-effectiveness analysis to inform drug copayment tiers. He utilized econometric methods to quantify the impact of the VBF on beneficiary medication utilization behavior, health outcomes and health care expenditures from beneficiary and payer perspectives. For this work Dr. Yeung successfully competed for two research grants: a multidisciplinary research training grant from the National Center for Advancing Translational Sciences of the NIH and a health services research dissertation grant from the Agency for Healthcare Research and Quality. Different portions of this project have been recognized by the International Society for Pharmacoeconomics and Outcomes Research 2014 and 2015 annual meetings as the best student podium presentation award, and at the Vancouver Health Economics Methodology 2016 meeting as the best student paper award.

    During his PharmD training, Dr. Yeung has cultivated a broad perspective in the expanded use of evidence and analytics in decision-making, having worked with a diverse group of health care stakeholders, including:

    - patients (clinical pharmacy),
    - health care payers (Kaiser Permanente Drug Information Services),
    - federal agencies (AHRQ and FDA),
    - professional organizations (Academy for Managed Care Pharmacy), and
    - international technology assessment organizations (National Institute for Health and Clinical Excellence, UK).

    At KPWHRI, Dr. Yeung uses econometric methods to study questions related to drug benefits, specialty drug cost and outcomes, and designing value-based financial incentives.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yeung K, Zhu W, McCurry SM, Von Korff M, Wellman R, Morin CM, Vitiello MV. Cost-effectiveness of telephone cognitive behavioral therapy for osteoarthritis-related insomnia. J Am Geriatr Soc. 2022 Jan; 70(1):188-199. PMID: 34633061; PMCID: PMC8742775.
      Citations:    Fields:    Translation:Humans
    2. Yeung K, Ulloa E. Incentivizing Prescription Drug Switching to Reduce Patient and Health Plan Spending: A Microsimulation Model. Value Health. 2022 03; 25(3):427-434. PMID: 35227455.
      Citations:    Fields:    Translation:Humans
    3. Yeung K, Dusetzina SB, Basu A. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018. JAMA Netw Open. 2021 Jun 01; 4(6):e2113393. PMID: 34125219; PMCID: PMC8204201.
      Citations:    Fields:    Translation:Humans
    4. Yeung K, Dusetzina SB. Prescription Drug Out-of-Pocket Cost Reduction Programs: Incentives and Implications. JAMA Intern Med. 2021 Jun 01; 181(6):765-766. PMID: 33779700.
      Citations:    Fields:    Translation:Humans
    5. Yeung K, Dorsey CN, Mettert K. Effect of new Medicare enrollment on health, healthcare utilization, and cost: A scoping review. J Am Geriatr Soc. 2021 Aug; 69(8):2335-2343. PMID: 33721340.
      Citations:    Fields:    Translation:Humans
    6. Yeung K, Richards J, Goemer E, Lozano P, Lapham G, Williams E, Glass J, Lee A, Achtmeyer C, Caldeiro R, Parrish R, Bradley K. Costs of using evidence-based implementation strategies for behavioral health integration in a large primary care system. Health Serv Res. 2020 12; 55(6):913-923. PMID: 33258127; PMCID: PMC7704468.
      Citations: 3     Fields:    Translation:PHPublic Health
    7. Yeung K, Barthold D, Dusetzina SB, Basu A. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps. N Engl J Med. 2020 08 06; 383(6):558-566. PMID: 32757524.
      Citations:    Fields:    Translation:Humans
    8. Banegas MP, Rivera DR, O'Keeffe-Rosetti MC, Carroll NM, Pawloski PA, Tabano DC, Epstein MM, Yeung K, Hornbrook MC, Lu C, Ritzwoller DP. Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML. J Natl Compr Canc Netw. 2019 10 01; 17(10):1166-1172. PMID: 31590146; PMCID: PMC7145440.
      Citations: 5     Fields:    Translation:Humans
    9. Yeung K, Morgan SG. Should national pharmacare apply a value-based insurance design? CMAJ. 2019 07 22; 191(29):E811-E815. PMID: 31332049; PMCID: PMC6645923.
      Citations: 2     Fields:    Translation:Humans
    10. Yeung K. Value-Based Insurance Design: Current Evidence and Future Directions. J Manag Care Spec Pharm. 2019 Jul; 25(7):738-741. PMID: 31232202.
      Citations: 1     Fields:    Translation:Humans
    11. Yeung K, Suh K, Garrison LP, Carlson JJ. Defining and Managing High-Priced Cures: Healthcare Payers' Opinions. Value Health. 2019 06; 22(6):648-655. PMID: 31198181.
      Citations: 2     Fields:    Translation:Humans
    12. Yeung K, Suh K, Basu A, Garrison LP, Bansal A, Carlson JJ. Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs. J Manag Care Spec Pharm. 2017 Oct; 23(10):1084-1090. PMID: 28944726.
      Citations: 1     Fields:    Translation:Humans
    13. Yeung K, Li M, Carlson JJ. Using Performance-Based Risk-Sharing Arrangements to Address Uncertainty in Indication-Based Pricing. J Manag Care Spec Pharm. 2017 Oct; 23(10):1010-1015. PMID: 28944729.
      Citations: 9     Fields:    Translation:Humans
    14. Yeung K, Basu A, Marcum ZA, Watkins JB, Sullivan SD. Impact of a value-based formulary in three chronic disease cohorts. Am J Manag Care. 2017 Mar; 23(3 Suppl):S46-S53. PMID: 29648740.
      Citations: 1     Fields:    Translation:Humans
    15. Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures. Med Care. 2017 Feb; 55(2):191-198. PMID: 27579915.
      Citations: 7     Fields:    Translation:Humans
    16. Sullivan SD, Yeung K, Vogeler C, Ramsey SD, Wong E, Murphy CO, Danielson D, Veenstra DL, Garrison LP, Burke W, Watkins JB. Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm. 2015 Apr; 21(4):269-75. PMID: 25803760.
      Citations: 14     Fields:    Translation:Humans
    17. Carlson JJ, Gries KS, Yeung K, Sullivan SD, Garrison LP. Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers. Appl Health Econ Health Policy. 2014 Jun; 12(3):231-8. PMID: 24664994.
      Citations: 11     Fields:    Translation:Humans
    18. Gold LS, Yeung K, Smith N, Allen-Ramey FC, Nathan RA, Sullivan SD. Asthma control, cost and race: results from a national survey. J Asthma. 2013 Sep; 50(7):783-90. PMID: 23638955.
      Citations: 3     Fields:    Translation:Humans
    19. Vo AA, Petrozzino J, Yeung K, Sinha A, Kahwaji J, Peng A, Villicana R, Mackowiak J, Jordan SC. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Transplantation. 2013 Mar 27; 95(6):852-8. PMID: 23511212.
      Citations: 19     Fields:    Translation:Humans
    Concepts (110)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _
    -->

    © 2022 Kaiser Permanente